|
|
Basf News (NYSE:BF)
| Latest Basf News Headlines | | Date | Time | Source | | | 05/17/2007 | 9:25AM | PRNUS | Diversa Achieves Milestones Under Alliance with BASF to Develop Innovative New Enzyme Products
SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA), a leader in the development of high-performance specialty enzymes, announced today that it has achieved two important product development milestones under its collaboration agreement with BASF (NYSE:BF), which have resulted in two payments... More...>> |
| 03/21/2007 | 9:18AM | PRNUS | MultiVu Video Feed: BASF and Monsanto Announce R&D and Commercialization Collaboration Agreement in Plant Biotechnology
Agreement Aimed at Developing Higher-Yielding Crops That Are More Tolerant To Adverse Environmental Conditions
NEW YORK, March 21 /PRNewswire-FirstCall/ -- BASF (NYSE:BF) and Monsanto Company (NYSE:MON) have announced a long-term joint research and development (R&D) and commercialization collaboration in plant biotechnology... More...>> |
| 03/21/2007 | 8:00AM | PRNUS | BASF and Monsanto Announce R&D and Commercialization Collaboration Agreement in Plant Biotechnology
-- Agreement aimed at developing higher-yielding crops that are more tolerant to adverse environmental conditions such as drought
LUDWIGSHAFEN, Germany and ST. LOUIS, March 21 /PRNewswire-FirstCall/ -- BASF (NYSE:BF) and Monsanto Company (NYSE:MON) today announced a long-term joint research and development (R&D) and... More...>> |
| 03/05/2007 | 8:30AM | PRNUS | BASF Corporation Signs Three-Year, Multi-Million Dollar Managed Services Agreement With BT
BT to Provide MPLS-Based WAN Platform
NEW YORK, March 5 /PRNewswire-FirstCall/ -- BT announced today that BT Americas Inc. has entered into a three-year, multi-million dollar managed services agreement with BASF Corporation (NYSE:BF), the world's largest chemical company, to deliver and manage a wide area network (WAN... More...>> |
| 11/02/2006 | 2:58AM | PRNUS | BASF Completes EUR500 Million Share Buyback Program and Plans to Repurchase Shares for a Further EUR500 Million
LUDWIGSHAFEN, Germany, November 2 /PRNewswire-FirstCall/ -- At the end of October 2006, BASF (NYSE:BF) completed its EUR500 million share buyback program that it announced in February 2006. Under the program, a total of 7.9 million shares was bought back at an average price of EUR63.11.
The Board of Executive Directors... More...>> |
| 04/28/2006 | 1:00PM | PRNUS | MZ Announces Conclusion of North American Company Reports Related to the 2006 Investor Relations Global Rankings (IRGR) and Awa
NEW YORK, April 28 /PRNewswire/ -- MZ Consult NY LLC (http://www.mz-ir.com/), a leading investor relations and financial communication consulting firm, today announced the conclusion and distribution of all 2006 IR Global Rankings (http://www.irglobalrankings.com/) reports for IR websites, Corporate Governance and Earnings... More...>> |
| 04/28/2006 | 4:00AM | PRNUS | MZ Announces Conclusion of European Company Reports Related to the 2006 Investor Relations Global Rankings (IRGR) and Awards
NEW YORK, April 28 /PRNewswire/ -- MZ Consult NY LLC (http://www.mz-ir.com/), a leading investor relations and financial communication consulting firm, today announced the conclusion and distribution of all 2006 IR Global Rankings (http://www.irglobalrankings.com/) reports for IR websites, Corporate Governance and Earnings... More...>> |
| 02/16/2006 | 9:30AM | PRNUS | BASF and Diversa Form Broad Alliance to Develop Innovative New Products
SAN DIEGO and LUDWIGSHAFEN, Germany, Feb. 16 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA) and BASF (NYSE:BF) announced today that they have entered into a broad alliance that will leverage Diversa's leadership position in novel enzyme development and BASF's expertise in biotechnology, process development... More...>> |
| 12/01/2003 | 6:30AM | PRNUS | Diversa Licenses Enzyme for Chiral Intermediate to BASF
Diversa Licenses Enzyme for Chiral Intermediate to BASF
SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- Diversa Corporation has licensed a
proprietary enzyme for the biocatalytic synthesis of a pharmaceutical
intermediate to BASF . BASF will produce the biocatalyst and apply it in one of
their proprietary biocatalytic... More...>> |
|
|
|